KalVista Pharmaceuticals, Inc. Common Stock
Own 3 of KALV at $11.50
|Range Today||$11.84 - $13.91|
|52 Week Range||$5.48 - $15.80|
KalVista Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. It offers small molecule plasma kallikrein for the treatment of hereditary angioedema; diabetic macular edema; and other plasma kallikrein-associated diseases. The company was founded by Crockett, T. Andrew, Edward P. Feener, and Lloyd P. Aiello and is headquartered in Cambridge, MA.